1. From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts;3the Department of Ophthalmology, Friedrich-Alexander-University Erlangen-Nu¨rnberg, Erlangen, Germany.2Present affiliation: Department of
2. Regeneron Pharmaceuticals Inc., Tarrytown, New York; the
3. From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts;
4. Medical Research Council Human Immunology Unit, Institute of Molecular Medicine, Oxford, United Kingdom; and
5. the Department of Ophthalmology, Friedrich-Alexander-University Erlangen-Nu¨rnberg, Erlangen, Germany.